Reviews on Antimicrobial Peptides
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Antimicrobial Peptides".
Deadline for manuscript submissions: closed (15 February 2024) | Viewed by 33795
Special Issue Editor
Interests: antimicrobial peptides; antibacterial; antibiotics; structure-activity relationships; bacteriocins; drug design; peptide engineering
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Antimicrobial peptides (AMPs) are part of the arsenal of host defense molecules that are present in numerous (more or less complex) life forms, from prokaryotes to eukaryotes. Because AMPs have shown unique antimicrobial properties in terms of potency and selectivity, they are currently emerging as candidate chemotherapeutic agents against pathogenic microbes, especially harmful Gram-positive and Gram-negative bacteria, including those resistant to conventional antibiotics. This Special Issue of Antibiotics titled ‘Reviews on Antimicrobial Peptides’ deals with all aspects of AMPs (from natural or nonnatural sources), from their discovery to their structural and functional characterization on microbes, as well as their evaluation in clinical trials. Potential contributors are strongly encouraged to submit their best review articles in this important field of applied scientific research.
Dr. Jean-Marc Sabatier
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antimicrobial peptides
- antibacterial peptides
- peptide antibiotics
- microbes
- bacteria
- bacteriocins
- bacterial resistance
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.